News Minimalist logo

News Minimalist

All news ranked by significance

GLP-1 drugs reduce cancer risks for diabetes patients

Finimize — July 5, 2024, 05:00 PM UTC

Summary: A study reveals that diabetes patients on GLP-1 drugs, like Ozempic, have lower risks of 10 obesity-related cancers. GLP-1 therapies, including Ozempic and Mounjaro, have shown significant benefits for blood sugar control and weight loss. The study, analyzing 1.6 million patients, was published on July 5, 2024, in JAMA Network Open. Novo Nordisk and Eli Lilly are experiencing increased profits due to the popularity of these treatments.

Full article

Article metrics
Significance5.1
Scale & Impact0.0
Positivity7.0
Credibility7.5
What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

  1. [3.2]
    Weight loss drugs may enhance brain health in diabetes (Gizmodo)
    90d 9h
    Source
  2. [4.5]
    GLP-1 drugs offer benefits beyond obesity and diabetes (News-Medical.Net)
    90d 15h
    Source
  3. [3.3]
    Dr. Daniel Drucker discusses future of Ozempic-like drugs (New York Post )
    95d 7h
    Source
  4. [4.0]
    Semaglutide not linked to higher neuropsychiatric risks in T2DM (News-Medical.Net)
    96d 15h
    Source
  5. [2.7]
    Oral semaglutide matches DPP-4i in T2D adherence, persistence (News-Medical.Net)
    97d 22h
    Source
  6. [4.6]
    Ozempic linked to cognitive benefits in diabetes patients (PMLiVE)
    98d 14h
    Source
  7. [3.2]
    AI analysis of Reddit shows interest in GLP-1 drugs for weight loss and mental health benefits (News-Medical.Net)
    99d 0h
    Source
  8. [2.5]
    Semaglutide may pose risk of vision loss: Study urges caution (Business Standard)
    99d 21h
    Source
  9. [4.7]
    Ozempic improves heart and kidney health for diabetes patients (Sydney Morning Herald)
    100d 17h
    Source
  10. [4.9]
    Semaglutide (Ozempic) may reduce dementia risk and nicotine cravings (Neuroscience News)
    101d 5h
    Source
  11. [3.2]
    Ozempic linked to lower dementia risk, nicotine use - study (The Straits Times)
    101d 8h
    Source
  12. [3.2]
    Ozempic linked to lower dementia risk, nicotine use in study (The Globe and Mail)
    101d 8h
    Source
  13. [3.9]
    Antidiabetic drugs linked to lower dementia risk in T2DM (News-Medical.Net)
    101d 9h
    Source
  14. [4.0]
    Ozempic linked to lower dementia rate in Oxford study (BNN Bloomberg)
    101d 17h
    Source
  15. [3.5]
    Ozempic and similar drugs may lower cancer risks (Forbes Australia)
    101d 22h
    Source
  16. [3.3]
    GLP-1 agonists lower dementia risk for diabetes patients (PsyPost)
    102d 1h
    Source
  17. [3.9]
    Weight-loss jabs lower cancer risk compared to insulin - study (The Conversation)
    102d 10h
    Source
  18. [4.7]
    GLP-1 agonists reduce cancer risk in type 2 diabetes (Inside Precision Medicine)
    103d 10h
    Source
  19. [3.4]
    GLP-1s reduce cancer risk in type 2 diabetes patients (PMLiVE)
    103d 14h
    Source
  20. [3.9]
    GLP-1 drugs linked to lower cancer risks in diabetes patients (Ars Technica)
    104d 10h
    Source
  21. [3.5]
    Semaglutide linked to rare eye disease causing vision loss (ScienceAlert)
    104d 15h
    Source
  22. [2.2]
    Semaglutide linked to higher risk of NAION in study (The Express Tribune)
    105d 13h
    Source
  23. [2.5]
    Semaglutide (Ozempic) linked to increased risk of blindness (Insight)
    105d 22h
    Source
  24. [5.5]
    GLP-1 agonists like Ozempic lower cancer risks in study (ScienceAlert)
    105d 23h

    ScoresSource
  25. [5.3]
    GLP-1 meds like Ozempic, Wegovy may lower cancer risk (CTV News)
    106d 12h

    ScoresSource
  26. [4.4]
    GLP-1 diabetes drugs reduce cancer risk, study finds (The Manila Times)
    107d 10h
    Source
  27. [5.0]
    GLP-1 medications may lower risk of certain cancers (CNN)
    108d 1h

    ScoresSource
  28. [2.2]
    GLP-1s lower risk of 10 obesity-related cancers in diabetes (Medpage Today)
    108d 5h
    Source
  29. [5.2]
    GLP-1 drugs like Ozempic may reduce cancer risk (Quartz)
    108d 6h

    ScoresSource
  30. [5.1]
    GLP-1 treatments reduce cancer risk in diabetes patients (GMA News Online)
    108d 7h

    ScoresSource
  31. [1.3]
    Weight loss drugs linked to rare eye condition risk (India TV News)
    108d 22h
    Source
  32. [2.9]
    Weight-loss drugs may increase risk of rare blindness (Firstpost)
    109d 14h
    Source
  33. [3.2]
    Novo Nordisk weight loss drugs linked to rare eye condition (CNBC)
    109d 16h
    Source
  34. [3.3]
    Ozempic linked to rare blindness cases in study (Business Insider)
    110d 8h
    Source
  35. [3.2]
    Wegovy, Ozempic linked to sight-threatening eye disorder in study (GMA News Online)
    110d 10h
    Source
  36. [3.4]
    Weight loss and diabetes drugs linked to rare blindness risk (CNN)
    110d 11h
    Source
  37. [3.2]
    Weight-loss jabs linked to potential blindness risk in study (The Guardian)
    110d 11h
    Source